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Summary 
A selective N-methyl-D-aspartate antagonist, DL-2-amino- 
5-phosphonovalerate, was found to produce PCP-like cata- 
lepsy, discriminative stimulus effects, and stereotyped 
operant responding in pigeons when administered intra- 
muscularly. These results support the hypothesis that the 
behavioral effects of PCP-llke drugs result at least in 
part from reduced neurotransmlssion at excitatory amino 
acid synapses utilizing N-methyl-D-aspartate preferring 
receptors. 
Phencyclldine (PCP) - like drugs selectively antagonize excitation of 
spinal neurons by N-methyl-D-aspartate (NMDA) [e.g., 1,2] and inhibit N/~)A- 
stimulated efflux of acetylchollne in rat striata [3]. The behavioral 
effects of PCP-like drugs might result from reduced neurotransmission at 
excitatory synapses utilizing NMDA preferring receptors. If this hypothesis 
is correct, drugs that are known to antagonize effects of NMDA should produce 
PCP-like behavioral effects. 
Recently, we reported that intracerebroventricular (i.c.v.) adminis- 
tration of DL-2-~m4no-5-phosphonovalerate (AP5), a potent and highly selec- 
tive NMDA antagonist [4], produces PCP-like catalepsy in pigeons [5]. In 
addition, the ability of NMDA-antagonists to induce PCP-like catalepsy 
appears to be correlated with their relative potency as NMDA antagonists [6]. 
Together, these findings constitute evidence for the mediation of a behavio- 
ral effect of PCP-llke drugs by inhibition of neurotransmission at excitatory 
synapses utilizing NMDA preferring receptors. The present study examines 
whether other behavioral actions of PCP-like drugs may be mediated in a 
similar fashion. 
First, we studied whether AP5, administered by intramuscular injection 
(i.m.), produces PCP-like catalepsy in pigeons. This experiment was done to 
study whether i.m. administration would produce behavioral effects similar to 
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those observed previously after i.c.v, administration, and to establish the 
potency relation between these routes of administration. Second, the ability 
of AP5 (i.m.) to produce PCP-like discriminative stimulus effects was 
studied. Drug discrimination, a procedure which yields results of consi- 
derable pharmacological specificity, was used to investigate the similarity 
of AP5 to PCP with respect to interoceptive stimulus effects. Third, the 
ability of AP5 (i.m.) to produce PCP-like stereotyped responding was inves- 
tigated. PCP induces grossly observable stereotypy in rats, but does not in 
pigeons; however, we have found PCP to increase the probability of repetition 
of non-relnforced responses in pigeons, as described herein, using an 
adaptation of an operant procedure that has been employed to study 
drug-induced stereotypy in rats [7]. 
Methods 
Subjects. Fourteen White Carneaux pigeons were housed individually with 
water and grit freely available. Eight pigeons had continuous access to 
mixed grain. Six pigeons were maintained at 80% of their free-feeding weight 
by providing mixed grain in the home cage after each experimental session. 
Catalepsy. This procedure has been described in detail elsewhere [8]. 
During an experimental session, drug injections were given i.m. (I ml/kg) at 
20-min intervals and effects (i.e., presence or absence of catalepsy, defined 
as loss of righting without head-drop and without eye closure) were assessed 
15 min after each injection. Each injected dose (after the first) was 
calculated such that the total amount injected before each test was ~ or % 
log-unit greater than the previous dose. Cumulative dosing continued until a 
dose was reached that produced catalepsy in each subject. The time course of 
the drug effect was studied by tests at successive time intervals after the 
last injection. Four of the eight pigeons, which had free access to food, 
were tested with PCP. The remaining four pigeons were tested with AP5. The 
lowest dose which produced catalepsy (referred to as the catalepsy threshold 
dose) and the longest time interval after the last injection of the session 
at which catalepsy was present (in mln), were determined for each pigeon. 
Discriminative stimulus effects. Three food-deprived pigeons were trained to 
discriminate between an i.m. injection of PCP (i mg/kg) and of saline, using 
operant conditioning chambers which contained two response keys and a hopper 
through which mixed grain was made available for reinforcement. Each daily 
session was preceded by an injection of either PCP or saline, after which the 
pigeon was placed in the experimental chamber. After i0 min, during which 
the chamber was dark and key-peck responses had no programmed consequences, 
the house-light came on and the left and the right key were illuminated red. 
Drug and saline sessions alternated according to a double alternation se- 
quence. Twenty responses on the Injectlon-appropriate key (i.e., left key 
PCP-appropriate, right key sallne-appropriate) resulted in 4-sec access to 
mixed grain. Responses on the inappropriate key had no programm%ed conse- 
quences. A session ended after 50 reinforcements or 1 hr, whichever occurred 
first. When the training criterion was met (i.e., less than 5 responses on 
the inappropriate key, prior to the first food presentation, during i0 
consecutive sessions), test sessions and training sessions were alternated. 
A test session ended when 20 responses had been made on either key or after 1 
h, whichever occurred first. The key on which 20 responses accumulated first 
was defined as the selected key. 
Tests were conducted only if the Injection-appropriate key was selected 
during both the immediately preceding drug training session and saline 
training session, otherwise drug and saline training sessions were alternated 
until the appropriate key was selected during two consecutive sessions. The 
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percentage of PCP-key selections was used as a measure of PCP-like 
discriminative stimulus effects. The lowest dose that produced selection of 
the PCP key (generalization threshold dose) was determined for each subject, 
for each drug. Selection latency was defined as the time between illumina- 
tion of the response keys and the occurrence of key selection. Each dose of 
PCP and of AP5 was tested twice. AP5 was tested using an injection-test 
interval of 30 min; PCP was evaluated i0 min after its administration. 
Stereotypy. An operant procedure used to study drug-lnduced stereotypy in 
rats [7] was adapted for use in pigeons. Three food-deprlved pigeons were 
trained to respond in an operant chamber. After 10 min, during which the 
chamber was dark and responses had no programmed consequences, the left and 
the right key were illuminated red. One of the two keys was selected random- 
ly (P = 0.5) to provide 3-sec access to grain following a key peck. Pecking 
the "unselected" key had no programmed consequences. After food had been 
presented, the computer program selected randomly which key would provide 
reinforcement next. The session ended after 60 reinforcements or after 1 hr, 
whichever occurred first. 
After performance had stabilized, every session was preceded by an 
injection of either sallne (S) or drug (D) according to the following, weekly 
repeating, sequence: S-D-S-D-S-D-S. Data obtained during the first saline 
session of each sequence were used to calculate control values. The probabi- 
lity that a response was repeated on the key "unselected" for food delivery 
was used as a measure of stereotyped responding and was calculated by divi- 
ding the number of repetitions by the sum of repetitions of, and switches 
between, left and right key responses. Rate of responding was measured as 
total number of responses divided by session length. Each dose of AP5 was 
tested twice, using an injection-test interval of 30 min; PCP was evaluated 
10 min after its administration. 
Statistical analysis. Data were analyzed by Student's t-test and by one- 
factor repeated measures ANOVA [9]. Post-hoc comparisons of particular doses 
with control were made using Dunnett's t-test. Threshold doses and selection 
latencies were log-transformed prior to statistical analysis. 
Dru~s. The compounds used were phencyclidine base (Warner-Lambert/ Parke- 
Davis and Co., Ann Arbor, MI) and DL-2-amino-5-phosphonovalerate hydro- 
chloride (Dr. P. 0rnstein). PCP was dissolved in sterile water to which a 
small amount of lactic acid was added. AP5 was dissolved in a minimum 
quantity of IN Na0H, to which sterile water was added. Doses of drugs are 
expressed in the forms described above. 
Results 
AP5 produced PCP-llke catalepsy when administered i.m. (Fig. 1, upper 
panel). The mean catalepsy threshold dose of AP5 (± 1 S.E.M.) was 195 ± 46 
mg/kg, which is about 120 times larger than the mean catalepsy threshold dose 
of PCP (i.e., 1.64 ± 0.58 mg/kg) (t = 11.02, df = 6, P < 0.001). The dura- 
tion of the AP5-induced catalepsy was significantly longer than the duration 
of the cataleptic effects of PCP (42N ± 69 min and 83 ± 23 mln, respectively; 
t = 4.64, df = 6, P < 0.01). 
PCP (1 mg/kg) acquired discriminative control over responding in all 
three pigeons, as evidenced by a dose-dependent effect on the percentage of 
PCP-key selections (Fig. 1, middle panel; mean generalization threshold 
dose: 0.72 ± 0.16 mg/kg). PCP did not significantly affect selection 
latency (F[4,8] < i.0; overall mean latency 10.9 ± 4.5 sec). AP5 produced 
PCP-appropriate responding at a mean generalization threshold dose of 139 ± 
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Fig. 1 
Upper panel: dose-response curves of PCP- and AP5-induced catalepsy (loss of 
righting without head-drop and without eye closure) in pigeons (n=4 per 
drug). Ordinate: percentage of subjects showing catalepsy. Abscissa: cumu- 
lative i.m. dose administered. Middle panel: discriminative stimulus effects 
of PCP and of AP5 in pigeons (n=3) trained to discriminate between i.m. 
injections of PCP (i mg/kg) and of saline. Each dose was tested twice. 
Ordinate: percentage of PCP-key selections. Abscissa: i.m. dose administered. 
Lower panel: stereotyped key pecking, ascertained by measuring the probabi- 
lity that non-reinforced responses are repeated after i.m. administration of 
PCP and of AP5, in pigeons (n=3). Each dose of AP5 was tested twice; each 
dose of PCP was tested once. Ordinate: probability of repetition of non- 
reinforced responses. Abscissa: i.m. dose administered. Dose-response curves 
of PCP-Induced discriminative stimulus effects and of PCP-induced stereotyped 
responding are replotted from other sources (Koek et al., Metaphlt, a pro- 
posed phencyclidlne receptor acylator: PCP-like behavioral effects and 
evidence of absence of antagonist activity in pigeons and in rhesus monkeys, 
J. Pharmacol. Exp. Ther. 237:386-392, Fig. 3). 
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41 mg/kg. The generalization threshold dose was about 190 times higher than 
the generalization threshold dose of PCP (t = 8.63, df = 2, P < 0.02]. AP5 
significantly increased selection latency (F[3,6] = 26.01, P < 0.001): the 
mean selection latency was significantly increased to 142 ± 65 sec after i00 
mg/kg of AP5 (P < 0.05), and to 1871 ± 349 sec after 180 mg/kg. 
PCP increased the probability of repetition of non-relnforced responses 
(Fig. 1, lower panel~ F[5,10] = 17.85, P < 0.001); the probability of res- 
ponse repetition was increased significantly by 1 mg/kg of PCP (P < 0.01) and 
by 1.8 mg/kg of PCP (P < 0.01). The overall rate of responding was 0.40 ± 
0.02 responses/s after administration of saline. PCP decreased the overall 
rate of responding (F[5,10] = 7.20, P < 0.005); response rate was reduced to 
0.21 ± 0.06 responses/s by 1.8 mg/kg of PCP (P < 0.01). The AP5-induced 
increase of response repetition approached statistical significance (F[4,8] = 
3.64, P = 0.057); response repetition was increased by 180 mg/kg of AP5 (P < 
0.05). The overall rate of responding was not affected by AP5 (F[4,8] = 1.52, 
P > 0.20). 
Discussion 
AP5, a selective NMDA antagonist, produces PCP-like behavioral effects 
in pigeons. In a previous study, AP5 was found to induce PCP-like catalepsy 
in pigeons when administered i.c.v, at a dose of i ~mol [5]. PCP-induced 
catalepsy has been shown to be pharmacologically specific and stereoselec- 
rive, as evidenced by the observation that pentobarbital fails to induce 
catalepsy and that catalepsy is induced by the (+)-isomers but not by the 
(-]-isomers of PCP-like drugs [8]. The observation that AP5 produced PCP- 
like catalepsy supports the suggestion that NMDA-antagonism may underly the 
cataleptic effects of PCP-like drugs. AP5 produced PCP-like catalepsy in all 
pigeons, when administered i.m. in a dose of 32n mg/kg. Therefore, AP5 
appears to be about 700 times less potent when administered i.m. as compared 
to i.c.v, administration. This large potency difference is compatible with 
the finding that AP5 and related compounds cross the blood-brain barrier 
relatively poorly, and is similar to the potency ratio between i.c.v, and 
i.p. administered AP5 in blocking convulsions in mice [i0]. 
AP5 produced PCP-appropriate discriminative responding in all pigeons 
when administered i.m., and was about 190 times less potent than PCP. In 
pigeons, PCP-like drugs induce discriminative stimulus control that is 
distinct from pentobarbital and a variety of other drugs [11,12,13 and 
unpublished observations]. The result of the present study suggests that 
NMDA antagonism may underly the discriminative stimulus effect of PCP in 
pigeons. 
PCP induces stereotypy in rats. A procedure used to measure drug- 
induced stereotyped operant responding in rats [7] was adapted for use in 
pigeons and was found to be sensitive to the effects of PCP. PCP and AP5 
increased response repetition, which suggests that these drugs induced 
stereotyped operant responding. Drug-induced response repetition in this 
procedure is to some extent pharmacologically selective, in that response 
repetition was increased also by apomorphine, d-amphetamine, and pentobarbi- 
tal, but was not affected by behaviorally active doses of chlordiazepoxide, 
scopolamine, morphine, chlorpromazine and haloperidol [unpublished 
observations]. 
The results suggest that PCP produces discriminative stimulus effects 
and stereotyped responding at doses which are only marginally effective in 
producing catalepsy (Fig. i). However, AP5-induced discriminative stimulus 
effects, stereotyped responding and catalepsy appear to occur within a 
similar dose-range. This difference between PCP and AP5 deserves further 
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study because it may mean that NMDA-antagonists produce behavioral effects 
only at doses very close to the cataleptic (and possibly anesthetic) dose, 
unlike PCP-type drugs. 
In conclusion, the NMDA-antagonist AP5 produced PCP-like catalepsy, 
discriminative stimulus effects and stereotyped operant responding in pi- 
geons. These results support the hypothesis that a reduction of neurotrans- 
mission at excitatory synapses utilizing NMDA receptors underlies certain be- 
havioral effects of PCP in pigeons. One of the implications of this hypo- 
thesis is that NMDA antagonists might have PCP-like psychotomimetic and 
anesthetic actions and potentially could yield a new class of anesthetic 
agents. 
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